Equity

BGF World Healthscience Fund

Overview

Important Information: Capital at Risk. All financial investments involve an element of risk. Therefore, the value of your investment and the income from it will vary and your initial investment amount cannot be guaranteed.

Show Fewer
Loading

Performance

Performance

  • Returns


The figures shown relate to past performance. Past performance is not a reliable indicator of future results and should not be the sole factor of consideration when selecting a product or strategy.

Share Class and Benchmark performance displayed in USD, hedged fund benchmark performance is displayed in USD.

Performance is shown on a Net Asset Value (NAV) basis, with gross income reinvested where applicable. The return of your investment may increase or decrease as a result of currency fluctuations if your investment is made in a currency other than that used in the past performance calculation. Source: Blackrock

Chart

Performance chart data not available for display.
View full chart

Reinvestments

Record Date Ex-Date Payable Date
View full table

Key Facts

Key Facts

Size of Fund (Millions) as of 21-Feb-19 USD 4,032.756
Base Currency USD
Fund Launch Date 06-Apr-01
Inception Date 01-Jul-02
Asset Class Equity
Morningstar Category Sector Equity Healthcare
Benchmark Index MSCI WRLD HealthCare ND
Domicile Luxembourg
Regulatory Structure UCITS
Management Company BlackRock (Luxembourg) S.A.
ISIN LU0147404148
Bloomberg Ticker MLWORHC
Initial Charge 0.00%
Performance Fee 0.00%
SEDOL 7559378
Bloomberg Benchmark Ticker NDWUHC
Dealing Settlement Trade Date + 3 days
Dealing Frequency Daily, forward pricing basis
Minimum Initial Investment USD 5000
Minimum Subsequent Investment USD 1000
Use of Income Accumulating

Risk Indicator

Risk Indicator

1
2
3
4
5
6
7
Low Risk High Risk
Typically low rewards Typically high rewards

Ratings

Ratings

Morningstar Rating

Overall Morningstar Rating for BGF World Healthscience Fund, Class C2, as of 31-Jan-19 rated against 280 Sector Equity Healthcare Funds.

Holdings

Holdings

as of 31-Jan-19
Name Weight (%)
UNITEDHEALTH GROUP INC 5.38
PFIZER INC 5.11
ABBOTT LABORATORIES 5.08
BOSTON SCIENTIFIC CORP 4.41
ROCHE HOLDING PAR AG 3.89
Name Weight (%)
NOVARTIS AG 3.50
MERCK & CO INC 3.31
ASTRAZENECA PLC 3.28
SANOFI SA 3.02
MEDTRONIC PLC 2.73
Holdings subject to change

Pricing & Exchange

Investor Class Currency Distribution Frequency NAV NAV Amount Change NAV % Change 52wk High 52wk Low Bid Price ISIN Offer Price TIS
Class C2 USD None 35.94 -0.09 -0.25 37.33 31.25 - LU0147404148 - -
Class D2 USD None 48.53 -0.12 -0.25 50.03 41.46 - LU0329593007 - -
Class A2 USD None 44.55 -0.11 -0.25 46.06 38.32 - LU0122379950 - -
Class X2 USD None 52.49 -0.12 -0.23 53.89 44.44 - LU0462856898 - -
Class A2 Hedged EUR None 10.70 -0.03 -0.28 11.22 9.65 - LU1822774284 - -
Class A2 Hedged AUD None 15.54 -0.04 -0.26 16.15 13.47 - LU1023059063 - -
Class A2 Hedged HKD None 154.14 -0.40 -0.26 160.06 133.83 - LU1061106388 - -
Class D2 EUR None 42.79 -0.11 -0.26 43.38 33.72 - LU0827889485 - -
Class A2 EUR None 39.28 -0.10 -0.25 39.88 31.16 - LU0171307068 - -
Class A2 Hedged CNH None 125.46 -0.31 -0.25 129.46 107.28 - LU1254117382 - -
Class A2 Hedged SGD None 15.50 -0.04 -0.26 16.11 13.47 - LU1057294990 - -
Class E2 USD None 40.80 -0.10 -0.24 42.26 35.24 - LU0122380701 - -
Class E2 EUR None 35.97 -0.10 -0.28 36.56 28.66 - LU0171309270 - -
Class C2 EUR None 31.68 -0.09 -0.28 32.26 25.41 - LU0331289677 - -
Class D4 USD Annual 11.11 -0.03 -0.27 11.45 9.52 - LU1728553774 - -

Portfolio Managers

Portfolio Managers

Erin Xie
Erin Xie

Literature

Literature